J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Ранг среди акций
#3880
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Цена акции
$26.58
Последняя синхронизация: 2026-07-23
Рыночная капитализация
$4.24B
Изменение (1 день)
0.00%
Изменение (1 год)
38.19%
Страна
IN
Торговля J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Категория
Healthcare
EPS для J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
EPS по состоянию на March 2026 TTM: $0.50
Согласно последним финансовым отчетам и цене акций J. B. Chemicals & Pharmaceuticals Limited, текущий EPS компании (TTM) составляет $0.50. В конце 2024 EPS компании составлял $0.43, больше, чем показателю 2023 года, равному $0.32.
История EPS компании J. B. Chemicals & Pharmaceuticals Limited с 2005 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $0.50 | -0.14% |
| 2025 | $0.50 | 16.04% |
| 2024 | $0.43 | 32.62% |
| 2023 | $0.32 | -1.80% |
| 2022 | $0.33 | -17.05% |
| 2021 | $0.40 | -13.65% |
| 2020 | $0.46 | 35.25% |
| 2019 | $0.34 | 33.94% |
| 2018 | $0.25 | -24.36% |
| 2017 | $0.33 | 15.70% |
| 2016 | $0.29 | 52.45% |
| 2015 | $0.19 | 56.65% |
| 2014 | $0.12 | -29.84% |
| 2013 | $0.17 | -89.07% |
| 2012 | $1.58 | 326.74% |
| 2011 | $0.37 | 18.09% |
| 2010 | $0.31 | 421.63% |
| 2009 | $0.06 | -55.22% |
| 2008 | $0.13 | -21.29% |
| 2007 | $0.17 | -13.10% |
| 2006 | $0.20 | 17.98% |
| 2005 | $0.17 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 11.42% |
IN
|
